News About: Pharm. Industry
Strategic alliances unavoidable course for domestic and foreign drugmakers
Business sources say that aggressive expansions through strategic alliances among drug manufacturers are inevitable amid rapid globalization of pharmaceutical markets.
Market insiders expect expects local and forei...
Priligy is popular in young people
Priligy (dapoxetine), which is marketed by Janssen Korea, is attracting the keenest attention from people in their 20s and 30s who have suffered premature ejaculation (PE).
Priligy has been prescribed to 70,000 Kor...
CJ to release Japan’s No. 1 painkiller
CJ Corporation said on January 27 that it will launch here Japan based Lion Corporation’s leading analgesic Bufferin tablets – Bufferin Lady and Bufferin Plus within this month.
This antipyretic analgesic formula f...
LG Life Sciences to raise overseas sales to 60%
LG Life Sciences (LGLS) painted a rosy picture for the company’s pharmaceutical business, saying it will increase its overseas sales by 60% in 2015, a company executive said on January 27.
“Biopharmaceutical busine...
International flu symposium to open Jan. 29
The Korea Research Institute of Bioscience and Biotechnology (KRBBA) and the International Vaccine Institute will hold an international symposium on influenza on January 29 to cope with the epidemic influenza.
Abou...
Bayer Healthcare to start ADVISE study
Bayer Healthcare said it will conduct its phase 4 study entitled “Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension” in the Asia-Pacific region.”
For ...
Yuyu to release natural antidepressant agent
Yuyu Pharm said it will St. John’s wort extract (brand name: Noiromin) containing its active ingredient hyperforin at pharmacy from next month.
According to the company, hyperforin exhibits significant antidepressa...
Hanmi introduce RFID system on pharmaceutical products
Hanmi Pharm said it has started to supply all of 300 drugs using the Radio Frequency Identification (RFID) service last December.
Hanmi said it is the first time that a local pharmaceutical manufacturer has used th...
Court rules in favor of Novartis over Glivec price
A Seoul court said on January 22 that it has ruled in favor of Novartis AG, the Swiss drug giant, who sought to overturn an earlier government decision to reduce the price of Glivec (imatinib mysylate) by 14 percent.
...
Low-priced drug incentive plan haunts drug makers
Local pharmaceutical manufacturers are attentively watching the government’ movement to implement the controversial low-priced drug incentive plan.
Pharmaceutical sources said the government is likely to make publi...
